Prion protein and metal interaction: Physiological and pathological implications

Current Issues in Molecular Biology

Volumn 12, Issue 2, 2010, Pages 99-108

  Singh, Neena ^a   Das, Dola ^a   Singh, Ajay ^a   Mohan, Maradumane L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL; PRION PROTEIN; PRION; PROTEIN BINDING;

BRAIN FUNCTION; METAL METABOLISM; NONHUMAN; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN FUNCTION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PRION; PRION DISEASES;

ANIMALIA;

ANIMALS; HUMANS; METALS; MODELS, BIOLOGICAL; PRION DISEASES; PRIONS; PROTEIN BINDING; PRPSC PROTEINS;

EID: 74749091456     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: 10.21775/9781912530076.04     Document Type: Review

References (102)

1. Aguzzi, A., and Polymenidou, M. (2004). Mammalian prion biology: one century of evolving concepts. Cell. 116, 313-327.
2. Abdelraheim, S.R., Královicová, S., and Brown, D.R. (2006). Hydrogen peroxide cleavage of the prion protein generates a fragment able to initiate polymerisation of full length prion protein. Int J Biochem Cell Biol. 38,1429-1440.
3. Barnham, K.J., and Bush, A.I. (2008). Metals in Alzheimer's and Parkinson's diseases. Curr. Opin. Chem. Biol. 12, 222-228.
4. Scin cells and infectious brain homogenate by redox-iron: Implications for prion replication and disease pathogenesis. Mol. Biol. Cell. 18, 3302-3312.
5. Beard, J.L., and Connor, J.R. (2003). Iron status and neural functioning. Ann. Rev. Nutr. 23, 41-58.
6. Bocharova, O.V., Breydo, L., Salnikov, V.V., and Baskakov, I.V. (2005) Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochem. 44, 6776-6787.
7. Bounhar, Y., Zhang, Y., Goodyer, C.G,, and LeBlanc, A. (2001). Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276, 39145-39149.
8. Brazier, M.W., Davies, P., Player, E., Marken, F., Viles, J.H., and Brown, D.R. (2008). Manganese binding to the prion protein. J. Biol. Chem. 283, 12831-12839.
9. Brown, D.R, Qin, K., Herms, J.W., Madlung, A., Manson, J., Strome, R., Fraser, P.E., Kruck, T., Von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D., and Kretzschmar, H. (1997). The cellular prion protein binds copper in vivo. Nature. 390, 684-687.
10. Brown, D.R., Hafiz, F., Glasssmith, L.L., Wong, B.S., Jones, I.M., Clive, C., and Haswell, S.J. (2000). Consequences of manganese replacement of copper for prion protein function and proteinase resistance, EMBO J. 19, 1180-1186.
11. Brown, D.R., Clive, C., and Haswell, S.J. (2001). Antioxidant activity related to copper binding of native prion protein. J. Neurochem. 76, 69-76.
12. Brown, D.R., Schmidt, B., and Kretzschmar, H.A. (1998). Effects of copper on survival of prion protein knockout neurons and glia. J. Neurochem. 70, 1686-1693.
13. Brown, L.R., and Harris, D.A. (2003). Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J. Neurochem. 87, 353-363.
14. Burns, C.S., Aronoff-Spencer, E., Legname, G., Prusiner, S.B., Antholine, W.E., Gerfen, G.J., Peisach, J., and Millhauser, G.L. (2003). Copper coordination in the full-length, recombinant prion protein. Biochem. 42, 6794-803.
15. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., DeArmond, S.J., Prusiner, S.B., Aguet, M., and Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356, 577-582.
16. Caughey, B., and Baron, G.S. (2006). Prions and their partners in crime. Nature 443, 803-810.
17. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., Caughey, B., Masliah, E., and Oldstone, M. (2005)Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439.
18. Deleault, N.R., Harris, B.T., Rees, J.R., and Supattapone, S. (2007). Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104, 9741-9746.
19. Fernaeus, S., and Land, T. (2005). Increased ironinduced oxidative stress and toxicity in scrapie-infected neuroblastoma cells. Neurosci. Lett. 382, 133-136.
20. Fernaeus, S., Halldin, J., Bedecs, K., and Land, T. (2005). Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res. Mol. Brain Res. 133, 266-273.
21. Gaasch, J.A., Lockman, P.R., Geldenhuys, W.J., Allen, D.D., and Van der Schyf, C.J. (2007). Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res. 32, 1196-1208.
22. Gerlach, M., Ben-Shachar, D., Riederer, P., and Youdim, M.B. (1994). Altered brain metabolism of iron as a cause of neurodegenerative diseases J Neurochem. 63, 793-807.
23. Giese, A., Buchholz, M., Herms, J., and Kretzschmar, H.A. (2005). Mouse brain synaptosomes accumulate copper-67 efficiently by two distinct processes independent of cellular prion protein. J. Mol. Neurosci. 27, 347-54.
24. Giese, A., Levin, J., Bertsch, U., and Kretzschmar, H.A. (2004). Effect of metal ions on de novo aggregation of full-length prion protein. Biochem. Biophys. Res. Commun. 320, 1240-1246.
25. Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., and Wolozin, B. (2002). Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein. J. Biol. Chem. 277, 16116-16123.
26. Gu, Y., Verghese, S., Mishra, R.S., Xu, X., Shi, Y., and Singh, N. (2003). Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity. J. Neurochem. 84, 10-22.
27. Harris, D.A., and True, H.L. (2006). New insights into prion structure and toxicity. Neuron. 50, 353-357.
28. Hayashi,T., Shoji, M., and Abe, K. (2006). Molecular mechanisms of ischemic neuronal cell death - with relevance to Alzheimer's disease. Curr Alzheimer Res. 3, 351-358.
29. Hegde, R.S., Mastrianni, J.A., Scott, M.R., DeFea, K.A., Tremblay, P., Torchia, M., DeArmond, S.J., Prusiner, S.B., and Lingappa, V.R. (1998). A transmembrane form of the prion protein in neurodegenerative disease. Science. 279, 827-834.
30. Hegde, R.S., Tremblay, P., Groth, D., DeArmond, S.J., Prusiner, S.B., and Lingappa, V.R. (1999). Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature. 402, 822-826.
31. Heller, U., Winklhofer, K.F., Heske, J., Reintjes, A., and Tatzelt, J. (2003). Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J. Biol. Chem. 278, 36139-36147.
32. Herms, J., Tings, T., Gall, S., Madlung, A., Giese, A., Siebert, H., Schürmann, P., Windl, O., Brose, N., and Kretzschmar, H. (1999). Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19, 8866-8875.
33. Hesketh, S., Sassoon, J., Knight, R., and Brown, D.R. (2008). Elevated manganese levels in blood and CNS in human prion disease. Mol. Cell Neurosci. 37, 590-598.
34. Hesketh, S., Sassoon, J., Knight, R., Hopkins, J., and Brown, D.R. (2007). Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy. J. Anim. Sci. 85, 1596-1609.
35. C may inhibit prion disease propagation. Brain Res. 12, 192-200.
36. Hornshaw, M.P., McDermott, J.R., and Candy, J.M. (1995a). Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207, 621-629.
37. Hornshaw, M.P., McDermott, J.R., Candy, J.M., and Lakey, J.H. (1995b). Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides, Biochem. Biophys. Res. Commun. 214, 993-999.
38. Jackson, G.S., Murray, I., Hosszu, L.L., Gibbs, N., Waltho, J.P., Clarke, A.R., and Collinge, J. (2001). Location and properties of metal-binding sites on the human prion protein, Proc. Natl. Acad. Sci. U. S. A. 98, 8531-8535.
39. Jeffrey, M., Goodsir, C.M., Race, R.E., and Chesebro, B. (2004). Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann. Neurol. 55, 781-792.
40. Jeong, S.Y., and David, S. (2003). Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27144-27148.
41. Jin, T., Gu, Y., Zanusso, G., Sy, M., Kumar, A., Cohen, M., Gambetti, P., and Singh, N. (2000). The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J. Biol. Chem. 275, 38699-38704.
42. Jobling, M.F., Huang, X., Stewart, L.R., Barnham, K.J., Curtain, C., Volitakis, I., Perugini, M., White, A.R., Cherny, R.A., Masters, C.L., Barrow, C.J., Collins, S.J., Bush, A.I., and Cappai, R. (2001). Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochem. 40, 8073-84.
43. Jobling, M.F., Stewart, L.R., White, A.R., McLean, C., Friedhuber, A., Maher, F., Beyreuther, K., Masters, C.L., Barrow, C.J., Collins, S.J., and Cappai, R. (1999). The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73, 1557-1565.
44. 2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J. Biol. Chem. 279, 32018-32027.
45. 2+ ions at physiological concentrations, J. Mol. Biol. 346, 1393-1407.
46. Kaplan, J. (2002). Mechanisms of cellular iron acquisition: another iron in the fire. Cell. 111, 603-606.
47. Kenward, A.G., Bartolotti, L.J., Burns, C.S. (2007). Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein. Biochem. 46, 4261-4271.
48. Kiachopoulos, S., Heske, J., Tatzelt, J., and Winklhofer, K.F. (2004). Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic. 5, 426-436.
49. Kim, B.H., Jun, Y.C., Jin, J.K., Kim, J.I., Kim, N.H., Leibold, E.A., Connor, J.R., Choi, E.K., Carp, R.I., and Kim, Y.S. (2007). Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice. Neurosci. Lett. 422, 158-163.
50. Kim, N.H., Choi, J.K., Jeong, B.H., Kim, J.I., Kwon, M.S., Carp, R.I., and Kim, Y.S. (2005). Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J. 19, 783-785.
51. Kim, N.H, Park, S.J., Jin, J.K., Kwon, M.S., Choi, E.K., Karp, R.I., and Kim, Y.S. (2000). Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice. Brain Res. 884, 98-103.
52. Kretzschmar, H.A., Tings, T., Madlung, A., Giese, A., Herms, J. (2000). Function of PrP(C) as a copper-binding protein at the synapse. Arch. Virol. Suppl. 16, 239-49.
53. Kristiansen, M., Messenger, M.J., Klohn, P.C., Brandner, S., Wadsworth, J.D., Collinge, J., and Tabrizi, S.J. (2005). Disease-related prion protein forms aggresomes in neuronal cells leading to caspase-activation and apoptosis. J. Biol. Chem. 280, 38851-38861.
54. Kuczius, T., Buschmann. A., Zhang, W., Karch, H., Becker, K., Peters, G., and Groschup, M.H. (2004). Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding. Biol. Chem. 385, 739-747.
55. Lee, K.S., Raymond, L.D., Schoen, B., Raymond, G.J., Kett, L., Moore, R.A., Johnson, L.M., Taubner, L., Speare, J.O., Onwubiko, H.A., Baron, G.S., Caughey, W.S., and Caughey, B. (2007). Hemin interactions and alterations of the subcellular localization of prion protein. J. Biol. Chem. 282, 36525-36533.
56. Liu, M., Yu, S., Yang, J., Yin, X., and Zhao, D. (2007). RNA and CuCl2 induced conformational changes of the recombinant ovine prion protein. Mol. Cell Biochem. 294, 197-203.
57. Sc-like conformation in the cytosol. Science. 298, 1785-1788.
58. Ma, J., Wollmann, R., and Lindquist, S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science. 298, 1781-1785.
59. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P.C., Brandner, S., and Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science. 302, 871-874.
60. Mishra, R.S., Basu, S., Gu, Y., Luo, X., Zou, W.Q., Mishra, R., Li, R., Chen, S.G., Gambetti, P., Fujioka, H., and Singh, N. (2004). Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J. Neurosci. 24, 11280-11290.
61. Mishra, R.S., Gu, Y., Bose, S., Verghese, S., Kalepu, S., Singh, N. (2002). Cell surface accumulation of a truncated transmembrane prion protein in Gerstmann-Straussler-Scheinker disease P102L. J. Biol. Chem. 277, 24554-24561.
62. Miura, T., Sasaki, S., Toyama, A., and Takeuchi, H. (2005). Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochem. 44, 8712-8720.
63. Moos, T., and Morgan, E.H. (2004). The metabolism of neuronal iron and its pathogenic role in neurological disease. Ann. N. Y. Acad. Sci. 1012, 14-26.
64. res amplification. J. Neurochem. 96, 1409-1415.
65. Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J.M., Farer, M., and Wolozin, B. (2000). The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 6048-6054.
66. Paik, S.R., Shin, H.J., and Lee, J.H. (2000). Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper (II) and hydrogen peroxide. Arch. Biochem. Biophys. 378, 269-277.
67. Pamplona, R., Naudí, A., Gavín, R., Pastrana, M.A., Sajnani, G., Ilieva, E.V., Del Río, J.A., Portero-Otín, M., Ferrer, I., and Requena, J.R. (2008). Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease. Free Radic Biol Med. 45, 1159-1166.
68. Pan, K.M., Stahl, N., and Prusiner, S.B. (1992). Purification and properties of the cellular prion protein from Syrian hamster brain, Protein Sci. 1, 1343-1352.
69. Pauly, P.C., and Harris, D.A. (1998). Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110.
70. Perera, W.S.S., and Hooper, N.M. (2001). Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol. 11, 519-523.
71. Petersen, R.B., Siedlak, S.L., Lee, H.G., Kim, Y.S., Nunomura, A., Tagliavini, F., Ghetti, B., Cras, P., Moreira, P.I., Castellani, R.J., Guentchev, M., Budka, H., Ironside, J.W., Gambetti, P., Smith, M.A., and Perry, G. (2005). Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. (Berl). 110, 232-238.
72. Prusiner, S.B. (1998). Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 3363-3383.
73. Qin, K., Yang, Y., Mastrangelo, P., and Westaway, D. (2002) Mapping Cu(II) binding sites in prion proteins by diethyl pyrocarbonate modification and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric footprinting. J. Biol. Chem. 277, 1981-1990.
74. Quaglio, E., Chiesa, R., and Harris, D.A. (2001). Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J. Biol. Chem. 276, 11432-11438.
75. Rossi, L., Lombardo, M.F., Ciriolo, M.R., and Rotilio, G. (2004). Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res. 29, 493-504.
76. Roucou, X., and LeBlanc, A.C. (2005). Cellular prion protein neuroprotective function: implications in prion diseases. J. Mol. Med. 83, 3-11.
77. Roucou, X., Gains, M., and LeBlanc, A.C. (2004). Neuroprotective functions of prion protein. J. Neurosci. Res. 75, 153-161.
78. Roucou, X., Giannopoulos, P.N., Zhang, Y., Jodoin, J., Goodyer, C.G., LeBlanc, A. (2005). Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 12, 783-795.
79. Sigurdsson, E.M., Brown, D.R., Alim, M.A., Scholtzova, H., Carp, R., Meeker, H.C., Prelli, F., Frangione, B., and Wisniewski, T. (2003). Copper chelation delays the onset of prion disease. J. Biol. Chem. 278, 46199-46202.
80. Singh, A., Isaac, A.O., Luo, X., Mohan, M.L., Cohen, M.L., Chen, F., Kong, Q., Bartz, J., and Singh, N. (2009a). Abnormal brain iron homeostasis in human and animal prion disorders. Plos Pathog. 5, e1000336.
81. Singh, A., Mohan, M.L., Isaac, A.O., Luo, X., and Singh, N. (2009b). Prion protein modulates cellular iron metabolism: Implications for prion disease pathogenesis. PlosOne. 4, e4468.
82. Singh, A., Kong, Q., Luo, X., Petersen, R.B., Meyerson, H., and Singh N. (2009c). Prion protein knock-out mice are iron deficient: A functional role for PrP in iron metabolism. Plos One. 4, e6115.
83. Smith, M.A., Harris, P.L., Sayre, L.M., and Perry, G. (1997). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 94, 9866-9868.
84. Smith, D.G., Cappai R., and Barnham K.J. (2007). The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta.1768,1976-1990.
85. Solforosi, L., Criado, J.R., McGavern, D.B., Wirz, S., Sánchez-Alavez, M., Sugama, S., DeGiorgio, L.A., Volpe, B.T., Wiseman, E., Abalos, G., Masliah, E., Gilden, D., Oldstone, M.B., Conti, B., and Williamson, R.A. (2004). Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science. 303, 1514-1516.
86. Stuermer, C.A., and Plattner, H. (2005). The 'lipid raft' microdomain proteins reggie-1 and reggie-2 (flotillins) are scaffolds for protein interaction and signalling. Biochem. Soc. Symp. 72, 109-118.
87. Takahashi, M., Ko, L.W., Kulathingal, J., Jiang, P., Sevlever, D., and Yen, S.H. (2007). Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D. Eur. J. Neurosci. 26, 863-874.
88. Thackray, A.M., Knight, R., Haswell, S.J., Bujdoso, R., and Brown, D.R. (2002). Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem. J. 362, 253-258.
89. Thompson, K.J., Shoham, S., and Connor, J.R. (2001). Iron and neurodegenerative disorders. Brain Res. Bull. 55, 155-164.
90. Treiber, C., Simons, A., and Multhaup, G. (2006). Effect of copper and manganese on the de novo generation of protease-resistant prion protein in yeast cells. Biochem. 45, 6674-6680.
91. Treiber, C., Thompsett, A.R., Pipkorn, R., Brown, D.R., Multhaup, G. (2007). Real-time kinetics of discontinuous and highly conformational metal-ion binding sites of prion protein. J. Biol. Inorg. Chem. 12, 711-720.
92. Tsenkova, R.N., Iordanova, I.K., Toyoda, K., and Brown, D.R. (2004). Prion protein fate governed by metal binding. Biochem. Biophys. Res. Commun. 325, 1005-1012.
93. Vassallo, N., and Herms, J. (2003). Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J. Neurochem. 86, 538-544.
94. Waggoner, D.J., Drisaldi, B., Bartnikas, T.B., Casareno, R.L., Prohaska, J.R., Gitlin, J.D., and Harris, D.A. (2000). Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275, 7455-7458.
95. Waheed, A., Grubb, J.H., Zhou, X.Y., Tomatsu, S., Fleming, R.E., Costaldi, M.E., Britton, R.S., Bacon. B.R., and Sly, W.S. (2002). Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 99, 3117-3122.
96. 2+ alters the distribution of Cu2+ coordination modes. J. Am. Chem. Soc. 129, 15440-15441.
97. Wang, X, Wang, F., Arterburn, L., Wollmann, R., and Ma, J. (2006). The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J. Biol. Chem. 281, 13559-13565.
98. Watt, N.T, and Hooper, N.M. (2003). The prion protein and neuronal zinc homeostasis. Trends Biochem. Sci. 28, 406-410.
99. Wong, B.S., Brown, D.R., Pan, T., Whiteman, M., Liu, T., Gambetti, P., Olesik, J., Rubenstein, R., and Sy, M.S. (2001a). Oxidative impairment in scrapie-infected mice is associated with brain metals. perturbations and altered antioxidant activities. J. Neurochem. 79, 689-698.
100. Wong, B.S., Chen, S.G., Colucci, M., Xie, Z., Pan, T., Liu, T., Li, R., Gambetti, P., Sy, M.S., and Brown, D.R. (2001b). Aberrant metal binding by prion protein in human prion disease. J. Neurochem. 78, 1400-1408.
101. Wong, B.S., Liu, T., Li, R., Pan, T., Petersen, R.B., Smith, M.A., Gambetti, P., Perry, G., Manson, J.C., Brown, D.R., and Sy, M-S. (2001c). Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein, J. Neurochem. 76, 565-572.
102. Sc modulates scrapie prion propagation. J. Biol. Chem. 279, 21948-21956.